Format

Send to

Choose Destination
Anticancer Res. 2000 Nov-Dec;20(6B):4153-7.

Apurinic/apyrimidinic endonuclease expression in pediatric yolk sac tumors.

Author information

1
Indiana University School of Medicine, Department of Pediatric Hematology/Oncology, Indianapolis, IN, USA. bthomson@iupui.edu

Abstract

BACKGROUND:

The enzyme apurinic/apyriminidic endonuclease/redox factor 1 (Ape1/ref1), a key protein in the base excision repair pathway, displays repair and redox activity. We examined the role of Ape1/ref1 and a protein it regulates, hypoxia inducible factor 1 alpha (HIF-1 alpha) in pediatric yolk sac tumors.

PATIENTS AND METHODS:

Using an immunohistochemical evaluation, 16 pediatric yolk sac tumors were evaluated for Ape1/ref1 and HIF-1 alpha expression. Samples were obtained from archival tissue.

RESULTS:

We demonstrated high levels of expression of Ape1/ref1 in 14/16 of the tumors. This expression was limited to the nucleus of the viable portion of each tumor. High levels of HIF-1 alpha expression was noted in half of the same tumors and localized to both the nucleus and cytoplasm of the viable tumor.

CONCLUSIONS:

The high levels of expression of Ape1/ref1 in this group of chemosensitive tumors may be related to the subcellular location or redox regulatory activity of one of the other factors controlled by Ape1/ref1.

PMID:
11205241
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center